Defect in formation of functional matrix vesicles by growth plate chondrocytes in avian tibial dyschondroplasia: evidence of defective tissue vascularization.
Avian tibial dyschondroplasia (ATD), a disease characterized by an almost total lack of mineralization in affected areas of growth plate cartilage, may involve defective matrix vesicle (MV) mineralization. To explore the biochemical defect in ATD, both normal and diseased tissue were analyzed for the amount of isolatable MVs, their chemical composition, and their ability to induce mineral formation. We found significantly fewer MVs in ATD tissue, and in contrast to normal MVs, which rapidly mineralized when incubated in synthetic cartilage lymph, those isolated from ATD lesions induced only limited mineralization even after prolonged incubation. Analysis by detergent extraction revealed a nearly dysfunctional nucleational core in ATD MVs. Thus, in ATD tissue, there is a defect in the formation of MVs, and those that form are nearly inactive. There were also alterations in the lipid-dependent Ca2+(-)binding proteins (annexins) in ATD MVs. There were lower levels of annexins II and VI in endogenously produced collagenase-released matrix vesicles (CRMVs), but not in matrix vesicle-enriched microsomes (MVEMs) produced by tissue homogenization. These findings indicate that there is insufficient Ca2+ in ATD cells to enable incorporation of the annexins into MVs. Finally, there was evidence of phospholipid breakdown in ATD MVs, as well as in ATD tissue generally. This indicated that the ATD lesions were becoming necrotic. Taken together, these findings indicate that there is a defect in tissue vascularization such that the supply of mineral ions and nutrients to ATD cartilage is inadequate to support normal MV formation and subsequent mineralization.
Nie
D
D
Department of Chemistry and Biochemistry, University of South Carolina, Columbia 29208, USA.
Genge
B R
BR
Wu
L N
LN
Wuthier
R E
RE
D000469:Alkaline Phosphatase / Q000378:metabolism; D000818:Animals; D017306:Annexin A2 / Q000378:metabolism; D017317:Annexin A6 / Q000378:metabolism; D001857:Bone Matrix / Q000098:blood supply / Q000187:drug effects / Q000473:pathology / Q000503:physiopathology*; D002113:Calcification, Physiologic / Q000502:physiology*; D002118:Calcium / Q000378:metabolism; D002645:Chickens; D017364:Collagenases / Q000378:metabolism; D006132:Growth Plate / Q000187:drug effects / Q000473:pathology / Q000503:physiopathology*; D008861:Microsomes; D010009:Osteochondrodysplasias / Q000378:metabolism / Q000503:physiopathology*; D010710:Phosphates / Q000378:metabolism; D013977:Tibia / Q000378:metabolism / Q000473:pathology; D015032:Zinc / Q000378:metabolism
D017306:Annexin A2; D017317:Annexin A6; D010710:Phosphates; D000469:Alkaline Phosphatase; D017364:Collagenases; D015032:Zinc; D002118:Calcium